Gynecologic Oncology Reports (Nov 2020)

Cytoreduction with hyperthermic intra peritoneal and intra thoracic chemotherapy for metastatic Sertoli-Leydig cell tumor of the ovary

  • Nicholas K. Larsen,
  • Matthew J. Reilly,
  • Seunghyug Kwon,
  • Brian W. Loggie,
  • Marcus W. Balters

Journal volume & issue
Vol. 34
p. 100638

Abstract

Read online

Sertoli Leydig cell tumor (SLCT) is a rare sex-cord stromal tumor of the ovary that generally has a benign course. Here, we report an unusual case of recurrent, metastatic SLCT and its unique management with a combination of cytoreductive surgery, hyperthermic intraperitoneal chemotherapy, hyperthermic intrathoracic chemotherapy, and systemic chemotherapy.

Keywords